{"id":"NCT00796926","sponsor":"Louis Tong","briefTitle":"Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes","officialTitle":"Randomised Controlled Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-07","primaryCompletion":"2010-11","completion":"2010-11","firstPosted":"2008-11-24","resultsPosted":"2011-08-12","lastUpdate":"2011-10-07"},"enrollment":30,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Xerophthalmia","Blepharitis"],"interventions":[{"type":"DRUG","name":"Systane Ultra eyedrops","otherNames":["Systane Ultra, Alcon"]},{"type":"DRUG","name":"Refresh eye drops","otherNames":["Refresh, Allergan"]}],"arms":[{"label":"Systane Ultra","type":"EXPERIMENTAL"},{"label":"Refresh","type":"ACTIVE_COMPARATOR"}],"summary":"Systane Ultra is at least as efficacious and safe as Refresh Tears in Asian people with Dry Eyes","primaryOutcome":{"measure":"Visual Analog Score (VAS)","timeFrame":"6 weeks","effectByArm":[{"arm":"Systane Ultra","deltaMin":21.55,"sd":16.8},{"arm":"Refresh","deltaMin":27.27,"sd":15}],"pValues":[{"comp":"OG000 vs OG001","p":">0.05"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Singapore"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":[]}}